United Kingdom · Question · Written question
UIN 9134
Multiple Sclerosis: Drugs
Introduced
11 June 2026
Last action
17 June 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
17 June 2026
Summary
To ask the Secretary of State for Health and Social Care, what steps he is taking to address variation in the proportion of people with multiple sclerosis starting a high-efficacy disease modifying therapy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 June 2026
Written question
To ask the Secretary of State for Health and Social Care, what steps he is taking to address variation in the proportion of people with multiple sclerosis starting a high-efficacy disease modifying therapy.
Source: Commons
17 June 2026
Answer
The Government recognises that there is geographical variation in England in the proportion of people with multiple sclerosis (MS) who are started on high-efficacy disease-modifying therapies (DMDs) and is committed to improving equitable access to the mo...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-06-11/9134
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1915312
- uk · wq-1915312 · source updated 17 June 2026